CNTO 859, a humanized anti‐tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models
Open Access
- 27 December 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (6) , 1261-1267
Abstract
Thromboembolic complications are frequently associated with advanced cancer. Interestingly, one of the major initiators of blood coagulation, tissue factor (TF), is reported to be overexpressed in several tumor types and can be found on both tumor cells and tumor vasculature. Although the exact mechanisms have yet to be elucidated, TF expressed on tumor cells can trigger intracellular signaling events through various pathways that can lead to tumor angiogenesis, proliferation, and metastasis. There exists preclinical evidence that disruption of TF dependent signaling can effectively inhibit tumor cell migration, metastasis, and angiogenesis. Here, we report for the first time that an antibody to tissue factor can also prevent tumor growth in vivo. Prophylactic administration of CNTO 859, a humanized anti‐human TF antibody, was shown to inhibit experimental lung metastasis of MDA‐MB‐231 human breast carcinoma cells by over 99% compared to a control antibody. Furthermore, therapeutic doses of CNTO 859 were shown to reduce tumor incidence and growth of orthotopically implanted MDA‐MB‐231 cells.Keywords
This publication has 41 references indexed in Scilit:
- Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and CancerArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Tissue factor enhances protease‐activated receptor‐2‐mediated factor VIIa cell proliferative propertiesJournal of Thrombosis and Haemostasis, 2005
- Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic DomainJournal of Biological Chemistry, 2004
- Oncogenes as Regulators of Tissue Factor Expression in Cancer: Implications for Tumor Angiogenesis and Anti-Cancer TherapySeminars in Thrombosis and Hemostasis, 2004
- Coagulation proteases and human cancerBiochemical Society Transactions, 2002
- Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesisBiochemical Society Transactions, 2002
- Diverse Functions of Protease Receptor Tissue Factor in Inflammation and MetastasisImmunologic Research, 2000
- Synergistic effect of coumadin and cytoxan in reducing lung metastasesJournal of Pediatric Surgery, 1986
- Reduced Incidence of Spontaneous Metastases with Long-Term Coumadin* TherapyAnnals of Surgery, 1968
- Effect of prolonged coumadin treatment on the production of pulmonary metastases in the ratCancer, 1966